I agree that this site is using cookies. You can find further informations here.
X
Marmé, Frederik
448  results:
?
1

GAIN2 trial overall survival with intense versus tailored d..:

Möbus, Volker ; Lück, Hans-Joachim ; Ladda, Ekkehart...
npj Breast Cancer.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

A plain language summary of the TROPiCS-02 study in patient..:

Rugo, Hope S ; Bardia, Aditya ; Marmé, Frederik...
Future Oncology.  20 (2024)  11 - p. 635-651 , 2024
Link: https://doi.org/10.2217/..
 
?
3

3-year invasive disease-free survival with chemotherapy de-..:

Pérez-García, José Manuel ; Cortés, Javier ; Ruiz-Borrego, Manuel...
The Lancet.  403 (2024)  10437 - p. 1649-1659 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Long-term Follow-up and Safety of Patients after an Upfront..:

Fasching, Peter A. ; Hein, Alexander ; Hack, Carolin C....
Geburtshilfe und Frauenheilkunde.  84 (2024)  2 - p. 185-195 , 2024
Link: https://doi.org/10.1055/..
 
?
5

Correction: Long-term Follow-up and Safety of Patients afte..:

Fasching, Peter A. ; Hein, Alexander ; Hack, Carolin C....
Geburtshilfe und Frauenheilkunde.  84 (2024)  2 - p. e10-e10 , 2024
Link: https://doi.org/10.1055/..
 
?
6

Patient-reported outcomes in high-risk HR+ /HER2- early bre..:

García-Sáenz, José Angel ; Marmé, Frederik ; Untch, Michael...
European Journal of Cancer.  196 (2024)  - p. 113420 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Health-related quality of life with sacituzumab govitecan i..:

Rugo, Hope S ; Schmid, Peter ; Tolaney, Sara M...
The Oncologist.  , 2024
Link: https://doi.org/10.1093/..
 
?
8

Current and emerging treatment approaches for hormone recep..:

Jhaveri, Komal ; Marmé, Frederik
Cancer Treatment Reviews.  123 (2024)  - p. 102670 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Impact of coadministration of proton-pump inhibitors and pa..:

Di Cosimo, Serena ; Pérez-García, José Manuel ; Bellet, Meritxell...
The Breast.  76 (2024)  - p. 103761 , 2024
Link: https://doi.org/10.1016/..
 
?
10

First-in-human study of naporafenib (LXH254) with or withou..:

Janku, Filip ; Kim, Tae Min ; Iyer, Gopakumar...
European Journal of Cancer.  196 (2024)  - p. 113458 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Baseline CD4+ and expansion of γδ T cells correlate with re..:

Massa, Chiara ; Karn, Thomas ; Weber, Karsten...
Clinical and Translational Medicine.  14 (2024)  4 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
12

Fibroblast Growth Factor Receptors and Ligands in Context o..:

Heublein, Sabine ; Pfisterer, Jacobus ; du Bois, Andreas...
Laboratory Investigation.  104 (2024)  4 - p. 100321 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Correction: Mcl-1 confers protection of Her2-positive breas..:

Bashari, Muhammad Hasan ; Fan, Fengjuan ; Vallet, Sonia...
Breast Cancer Research.  26 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
14

Systematic Analysis of Homologous Recombination Deficiency ..:

Romey, Marcel ; Rodepeter, Fiona ; Hattesohl, Akira...
Modern Pathology.  37 (2024)  4 - p. 100445 , 2024
Link: https://doi.org/10.1016/..
 
?
15

Prognostic impact of selection criteria of current adjuvant..:

Fasching, Peter A. ; Hack, Carolin C. ; Nabieva, Naiba...
European Journal of Cancer.  209 (2024)  - p. 114239 , 2024
Link: https://doi.org/10.1016/..
 
1-15